vs

Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

Harmony Biosciences Holdings, Inc. is the larger business by last-quarter revenue ($243.8M vs $162.5M, roughly 1.5× Bitcoin Depot Inc.). Harmony Biosciences Holdings, Inc. runs the higher net margin — 9.2% vs 3.4%, a 5.8% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs 20.1%). Harmony Biosciences Holdings, Inc. produced more free cash flow last quarter ($126.0M vs $2.5M). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs -4.9%).

Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

BTM vs HRMY — Head-to-Head

Bigger by revenue
HRMY
HRMY
1.5× larger
HRMY
$243.8M
$162.5M
BTM
Growing faster (revenue YoY)
HRMY
HRMY
+1.0% gap
HRMY
21.1%
20.1%
BTM
Higher net margin
HRMY
HRMY
5.8% more per $
HRMY
9.2%
3.4%
BTM
More free cash flow
HRMY
HRMY
$123.5M more FCF
HRMY
$126.0M
$2.5M
BTM
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
-4.9%
BTM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BTM
BTM
HRMY
HRMY
Revenue
$162.5M
$243.8M
Net Profit
$5.5M
$22.5M
Gross Margin
71.9%
Operating Margin
7.3%
15.8%
Net Margin
3.4%
9.2%
Revenue YoY
20.1%
21.1%
Net Profit YoY
690.4%
-54.6%
EPS (diluted)
$0.08
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTM
BTM
HRMY
HRMY
Q4 25
$243.8M
Q3 25
$162.5M
$239.5M
Q2 25
$172.1M
$200.5M
Q1 25
$164.2M
$184.7M
Q4 24
$201.3M
Q3 24
$135.3M
$186.0M
Q2 24
$163.1M
$172.8M
Q1 24
$138.5M
$154.6M
Net Profit
BTM
BTM
HRMY
HRMY
Q4 25
$22.5M
Q3 25
$5.5M
$50.9M
Q2 25
$6.1M
$39.8M
Q1 25
$4.2M
$45.6M
Q4 24
$49.5M
Q3 24
$-939.0K
$46.1M
Q2 24
$-2.6M
$11.6M
Q1 24
$-1.5M
$38.3M
Gross Margin
BTM
BTM
HRMY
HRMY
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
73.0%
Q3 24
77.0%
Q2 24
81.4%
Q1 24
82.2%
Operating Margin
BTM
BTM
HRMY
HRMY
Q4 25
15.8%
Q3 25
7.3%
27.3%
Q2 25
9.2%
24.0%
Q1 25
10.8%
30.4%
Q4 24
27.7%
Q3 24
4.1%
33.2%
Q2 24
4.7%
12.4%
Q1 24
0.5%
33.7%
Net Margin
BTM
BTM
HRMY
HRMY
Q4 25
9.2%
Q3 25
3.4%
21.2%
Q2 25
3.5%
19.8%
Q1 25
2.6%
24.7%
Q4 24
24.6%
Q3 24
-0.7%
24.8%
Q2 24
-1.6%
6.7%
Q1 24
-1.1%
24.8%
EPS (diluted)
BTM
BTM
HRMY
HRMY
Q4 25
$0.38
Q3 25
$0.08
$0.87
Q2 25
$0.16
$0.68
Q1 25
$0.20
$0.78
Q4 24
$0.85
Q3 24
$-0.05
$0.79
Q2 24
$-0.13
$0.20
Q1 24
$-0.25
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTM
BTM
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$59.3M
$775.3M
Total DebtLower is stronger
$67.5M
$163.7M
Stockholders' EquityBook value
$21.0M
$870.2M
Total Assets
$125.3M
$1.3B
Debt / EquityLower = less leverage
3.21×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTM
BTM
HRMY
HRMY
Q4 25
$775.3M
Q3 25
$59.3M
$672.6M
Q2 25
$48.0M
$565.3M
Q1 25
$35.0M
$507.0M
Q4 24
$467.2M
Q3 24
$32.2M
$410.5M
Q2 24
$43.9M
$346.9M
Q1 24
$42.2M
$372.4M
Total Debt
BTM
BTM
HRMY
HRMY
Q4 25
$163.7M
Q3 25
$67.5M
$168.5M
Q2 25
$66.5M
$172.1M
Q1 25
$56.2M
$175.7M
Q4 24
$179.3M
Q3 24
$44.5M
$182.8M
Q2 24
$41.2M
$186.4M
Q1 24
$37.6M
$190.0M
Stockholders' Equity
BTM
BTM
HRMY
HRMY
Q4 25
$870.2M
Q3 25
$21.0M
$835.1M
Q2 25
$4.7M
$773.1M
Q1 25
$-4.6M
$720.5M
Q4 24
$659.2M
Q3 24
$-7.9M
$596.8M
Q2 24
$4.4M
$538.6M
Q1 24
$5.0M
$515.4M
Total Assets
BTM
BTM
HRMY
HRMY
Q4 25
$1.3B
Q3 25
$125.3M
$1.2B
Q2 25
$109.1M
$1.1B
Q1 25
$89.7M
$1.1B
Q4 24
$999.2M
Q3 24
$87.4M
$928.1M
Q2 24
$97.5M
$858.4M
Q1 24
$90.1M
$847.0M
Debt / Equity
BTM
BTM
HRMY
HRMY
Q4 25
0.19×
Q3 25
3.21×
0.20×
Q2 25
14.18×
0.22×
Q1 25
0.24×
Q4 24
0.27×
Q3 24
0.31×
Q2 24
9.27×
0.35×
Q1 24
7.54×
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTM
BTM
HRMY
HRMY
Operating Cash FlowLast quarter
$6.6M
$126.2M
Free Cash FlowOCF − Capex
$2.5M
$126.0M
FCF MarginFCF / Revenue
1.6%
51.7%
Capex IntensityCapex / Revenue
2.5%
0.0%
Cash ConversionOCF / Net Profit
1.20×
5.61×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTM
BTM
HRMY
HRMY
Q4 25
$126.2M
Q3 25
$6.6M
$108.7M
Q2 25
$10.2M
$79.3M
Q1 25
$16.3M
$34.0M
Q4 24
$75.6M
Q3 24
$5.8M
$70.5M
Q2 24
$10.1M
$42.6M
Q1 24
$1.3M
$31.1M
Free Cash Flow
BTM
BTM
HRMY
HRMY
Q4 25
$126.0M
Q3 25
$2.5M
$108.7M
Q2 25
$9.8M
$79.3M
Q1 25
$15.9M
$33.9M
Q4 24
$75.0M
Q3 24
$-1.0M
$70.5M
Q2 24
$7.6M
$42.0M
Q1 24
$789.0K
$31.1M
FCF Margin
BTM
BTM
HRMY
HRMY
Q4 25
51.7%
Q3 25
1.6%
45.4%
Q2 25
5.7%
39.6%
Q1 25
9.7%
18.3%
Q4 24
37.3%
Q3 24
-0.8%
37.9%
Q2 24
4.7%
24.3%
Q1 24
0.6%
20.1%
Capex Intensity
BTM
BTM
HRMY
HRMY
Q4 25
0.0%
Q3 25
2.5%
0.0%
Q2 25
0.2%
0.0%
Q1 25
0.2%
0.1%
Q4 24
0.3%
Q3 24
5.0%
0.0%
Q2 24
1.5%
0.4%
Q1 24
0.4%
0.0%
Cash Conversion
BTM
BTM
HRMY
HRMY
Q4 25
5.61×
Q3 25
1.20×
2.14×
Q2 25
1.67×
1.99×
Q1 25
3.88×
0.75×
Q4 24
1.53×
Q3 24
1.53×
Q2 24
3.68×
Q1 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons